<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>PURPOSE: Catastrophic <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> (CAPS) is a variant of <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> and presents with life-threatening symptoms of multiorgan failure due to <z:mp ids='MP_0005048'>thrombosis</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>We present a patient with CAPS secondary to an <z:e sem="disease" ids="C1140680" disease_type="Neoplastic Process" abbrv="">ovarian cancer</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>In such cases, it is believed that the thrombotic risk disappears after surgical removal of the <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>The intraoperative management was challenging because of the risks of two opposing complications: catastrophic exacerbation of the thrombotic tendency triggered by the surgical stimulus and major <z:mp ids='MP_0001914'>bleeding</z:mp> due to the necessary anticoagulation </plain></SENT>
<SENT sid="4" pm="."><plain>We describe the intraoperative management of hemostasis in a patient with CAPS </plain></SENT>
<SENT sid="5" pm="."><plain>CLINICAL FEATURES: A 44-yr-old female patient with CAPS underwent resection of an <z:e sem="disease" ids="C1140680" disease_type="Neoplastic Process" abbrv="">ovarian cancer</z:e>, which was suspected to be associated with her <z:hpo ids='HP_0001928'>coagulation abnormality</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain>She had both arterial and venous <z:hpo ids='HP_0001907'>thromboembolism</z:hpo>, including <z:e sem="disease" ids="C0007785" disease_type="Disease or Syndrome" abbrv="">cerebral infarction</z:e>, embolic <z:hpo ids='HP_0100758'>gangrene</z:hpo>, and <z:e sem="disease" ids="C0034065" disease_type="Disease or Syndrome" abbrv="">pulmonary emboli</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>Serological examinations revealed increased anticardiolipin IgG antibody and decreased protein C activity </plain></SENT>
<SENT sid="8" pm="."><plain>Before surgery, an inferior vena cava filter was placed to prevent perioperative <z:hpo ids='HP_0002204'>pulmonary embolism</z:hpo> </plain></SENT>
<SENT sid="9" pm="."><plain><z:chebi fb="11" ids="26333">Prostaglandin</z:chebi> E(1) (<z:chebi fb="0" ids="26338">PGE</z:chebi>(1); 100 ng.kg(-1).min(-1)) was given intraoperatively to suppress platelet aggregation and thrombin generation and to maintain arterial blood flow </plain></SENT>
<SENT sid="10" pm="."><plain>No apparent <z:hpo ids='HP_0001928'>coagulation abnormalities</z:hpo> were observed during surgery, neither hypercoagulation nor a tendency to bleed </plain></SENT>
<SENT sid="11" pm="."><plain>No additional thrombotic symptoms developed during a six-month follow-up </plain></SENT>
<SENT sid="12" pm="."><plain>CONCLUSION: The use of <z:chebi fb="0" ids="26338">PGE</z:chebi>(1), an inhibitor of thrombin formation and platelet function, and placement of an inferior vena cava filter were associated with the uneventful surgical resection of an <z:e sem="disease" ids="C1140680" disease_type="Neoplastic Process" abbrv="">ovarian cancer</z:e> in a patient with CAPS </plain></SENT>
</text></document>